8 Extreme Value Stocks

NASDAQ: IOVA | Iovance Biotherapeutics, Inc. News, Ratings, and Charts

IOVA – POWR Rating of A + 44 to 91% upside potential = 8 extreme value stocks to explore today.

Value is becoming in short supply these days as the market presses back up towards the all time highs. Thus, investors have to dig a little deeper to find exceptional value opportunities.

Gladly 8 extreme value stocks emerged from my recent search. The key was not just to focus on value, but to also make sure the stock had other catalysts in place to help it achieve that upside in a timely fashion. That’s why I focused on stocks that were also sporting a POWR Rating of “A” Strong Buy.

As you probably have learned by now, the POWR Rating is centered on stocks experiencing the best momentum at this time. Typically that momentum is borne of a strong fundamental catalyst that serves to keep shares on the rise going forward.

Now let’s talk about the value portion of this search. There are many different measures of value like PE, Price to Sales, Book Value, PEG and more. However, I have found that the best singular criteria is the average target price generated by the analysts covering the stock.

Remember that every industry has different methods for valuation. For example, energy stock prices have a lot more to do with the value of proven reserves than the current level of sales or earnings. So the average target price takes all these different valuation methods into account and creates the singular best way to locate stocks with the most upside potential.

When you combine it together we are focusing on stocks experiencing the best momentum, based on strong fundamentals, and with the most upside potential to fair value according to Wall Street.

Here is the full list of 8 best value stocks on the market today:

Company Ticker Price Target Price Upside %
Chiasma Inc CHMA $7.82 $15.00 91.82%
Changyou.Com CYOU $10.31 $18.00 74.59%
Zymeworks Inc ZYME $20.50 $31.35 52.93%
Pretium Res Inc PVG $9.49 $14.40 51.74%
Iovance Biothpt IOVA $19.10 $28.13 47.28%
Telefonica S.A. TEF $8.30 $12.20 46.99%
Mag Silver Corp MAG $10.90 $15.75 44.50%
Century Casinos CNTY $9.01 $13.00 44.28%

Also here are links to 2 other popular destinations to make the best use of the POWR Ratings:

Full List of “A ”Rated Strong Buy Stocks

Reitmeister Total Return portfolio. This is where Steve Reitmeister employs his 40 years of investment experience to hand select the best POWR Ratings stocks.


shares closed at $289.26 on Friday, down $-0.32 (-0.11%). Year-to-date, has gained 16.25%, versus a % rise in the benchmark S&P 500 index during the same period.


This article is brought to you courtesy of StockNews.com.

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CYOUGet RatingGet RatingGet Rating
Get RatingGet RatingGet Rating
Get RatingGet RatingGet Rating
Get RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Why Are Stocks Floating Higher?

Why are stocks breaking above 6,000 once again? When will they make news highs? And what is an investor to do now? Seasoned investor Steve Reitmeister shares his thoughts in this updated commentary.

How is the Stock Market Like a Helium Balloon?

Stocks have finally broke above 6,000 for the S&P 500 (SPY). The more important question is what comes next? Steve Reitmeister provides his answer in his latest market commentary.

Has the Bull Market Run Out of Steam?

It seems the S&P 500 (SPY) advance has stalled and cant crack above strong resistance at 6,000. Why is that happening? And what happens next? Read on for the answers...

Investors Remain “Cautiously Optimistic”

The S&P 500 (SPY) has made great advances since the lows of early April. Yet seem to be stuck under resistance at 6,000. What happens next depends on tariff talks. So let’s talk about the latest news on that front.

Bull Market Til Proven Otherwise

The phrase that paid for investors in 2025 was “Bull market til proven otherwise” Steve Reitmeister explains why in his latest market update and preview of top stock picks.

Read More Stories

More Iovance Biotherapeutics, Inc. (IOVA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All IOVA News